EORTC protocol 22962

A phase III study comparing conventional versus hyperfractionated radiotherapy, with or without concomitant chemotherapy, in patients with head and neck squamous cell carcinoma.
Trial StatusAll trial activities ended
DatesDate of activation: 16-Dec-96
Closed on : 30-Apr-99
Data management at EORTCFull
Phase3
Randomized trialYes
Type-
Targeted Sample size994
Number of steps1
Drug
Study StaffJacques Bernier (Study Coordinator) - Clinique De Genolier, Genolier
Jean-Claude Horiot (Study Coordinator) - Clinique De Genolier, Genolier
Type of cancerHead and Neck
Participating GroupsEORTC Radiation Oncology Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section